To: Dave Johnson who wrote (7919 ) 7/11/1999 10:16:00 AM From: OldAIMGuy Respond to of 18931
Hi Dave, Nobody loves biotechs these days, everybody loves internets instead. NERX has had its problems over the years, but they have also continued to turn out interesting bits of science. It's a tiny bit of mortar in between the blocks of some of the speculative bricks at the peak of my investment pyramid. Certainly not foundation material. NERX lost a major sponsor back some time ago and the stock tanked to the $1 range and hasn't broken $2 often enough to take notice. However, between $1 and $2 one can make some AIM trades! Yes, I've owned it a long time, but a love affair I wouldn't call it. The Preferred Stock pays about 16.2% at the price I paid - definitely junk bond status, but I'll cash their checks quickly! :-) I've a mix of common and the preferred that gives me a civil return while waiting for these folks to get their scientific act together. Most recent news from the company was quite good regarding certain types of cancers. They've developed a "pre-target" therapy which delivers a "magic bullet" to the cancerous tumor while remaining relatively benign to the bodily tissues. They are neither the first or the only company working on this sort of treatment, but they have made progress and should eventually get some reward for their efforts. I plan on being there after a long AIM shot. It wasn't to my advantage to have EVER heard about this company! It's one of the sows ears left in my portfolio that's good enough to keep around because of "potential" but not yet good enough to turn into a Silk Purse. So far it's been a long, sad story. There's potential for a happy ending. Best regards, Tom PS: There's a NERX thread here on SI, but it's not very active. beta.siliconinvestor.com PPS: Don't know why the "charts" are not in good resolution.